2023-07-19T00:51:11Z
ENA-FIRST-PUBLIC
2023-07-19T00:51:11Z
ENA-LAST-UPDATE
GSM6732464
External Id
SAMN31740234
External Id
2023-07-19T00:51:11Z
INSDC first public
2023-07-19T00:51:11Z
INSDC last update
public
INSDC status
SRS15765579
SRA accession
GSM6732464
Submitter Id
NCBI
broker name
Expanded TIL
cell line
CD8+
cell type
missing
collection_date
human
common name
female
gender
missing
geo_loc_name
43%
infusion percent_cd4
27%
infusion percent_cd8
2.04E+10
number til_infused
Homo sapiens
organism
7
overall survival_months
1
pfs censor_at_12_months
4
pfs months
PD
response
Homo sapiens
scientific_name
TIL ACT Product
source_name
1
survival censor
TIL ACT Product
tissue
Patient 11 CD8+ [Pt11_CD8 RNA-seq]
title
TIL ACT
treatment
16992
trial